184 related articles for article (PubMed ID: 34027738)
1. Partial Personalization of Medical Treatment Decisions: Adverse Effects and Possible Solutions.
Weyant C; Brandeau ML
Med Decis Making; 2022 Jan; 42(1):8-16. PubMed ID: 34027738
[TBL] [Abstract][Full Text] [Related]
2. Personalizing Medical Treatment Decisions: Integrating Meta-analytic Treatment Comparisons with Patient-Specific Risks and Preferences.
Weyant C; Brandeau ML; Basu S
Med Decis Making; 2019 Nov; 39(8):998-1009. PubMed ID: 31707910
[No Abstract] [Full Text] [Related]
3. Personalization of Medical Treatment Decisions: Simplifying Complex Models while Maintaining Patient Health Outcomes.
Weyant C; Brandeau ML
Med Decis Making; 2022 May; 42(4):450-460. PubMed ID: 34416832
[TBL] [Abstract][Full Text] [Related]
4. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
5. Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care.
Pillay J; Guitard S; Rahman S; Saba S; Rahman A; Bialy L; Gehring N; Tan M; Melton A; Hartling L
Syst Rev; 2024 May; 13(1):140. PubMed ID: 38807191
[TBL] [Abstract][Full Text] [Related]
6. Personalizing Second-Line Type 2 Diabetes Treatment Selection: Combining Network Meta-analysis, Individualized Risk, and Patient Preferences for Unified Decision Support.
Choi SE; Berkowitz SA; Yudkin JS; Naci H; Basu S
Med Decis Making; 2019 Apr; 39(3):239-252. PubMed ID: 30767632
[TBL] [Abstract][Full Text] [Related]
7. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.
Hernández Alava M; Wailoo A; Pudney S; Gray L; Manca A
Health Technol Assess; 2020 Jun; 24(34):1-68. PubMed ID: 32613941
[TBL] [Abstract][Full Text] [Related]
8. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
9. Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit-risk assessment: the BRAINS study including expert workshop.
Totton N; Julious SA; Coates E; Hughes DA; Cook JA; Biggs K; Hewitt C; Day S; Cook A
Health Technol Assess; 2023 Oct; 27(20):1-58. PubMed ID: 37982521
[TBL] [Abstract][Full Text] [Related]
10. Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity.
Heath A; Pechlivanoglou P
Med Decis Making; 2022 Jul; 42(5):649-660. PubMed ID: 35023403
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based Shared-Decision-Making Assistant (SDM-assistant) for choosing antipsychotics: protocol of a cluster-randomized trial in hospitalized patients with schizophrenia.
Siafis S; Bursch N; Müller K; Schmid L; Schuster F; Waibel J; Huynh T; Matthes F; Rodolico A; Brieger P; Bühner M; Heres S; Leucht S; Hamann J
BMC Psychiatry; 2022 Jun; 22(1):406. PubMed ID: 35715740
[TBL] [Abstract][Full Text] [Related]
12. Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia.
Shafrin J; Schwartz TT; Lakdawalla DN; Forma FM
J Manag Care Spec Pharm; 2016 Nov; 22(11):1285-1291. PubMed ID: 27783545
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2018; 18(5):1-141. PubMed ID: 30443277
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of medical and economic benefits of antipsychotics in the treatment of schizophrenia in France].
Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
Encephale; 2017 Aug; 43(4):311-320. PubMed ID: 27623123
[TBL] [Abstract][Full Text] [Related]
16. Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study.
Knapp M; Windmeijer F; Brown J; Kontodimas S; Tzivelekis S; Haro JM; Ratcliffe M; Hong J; Novick D;
Pharmacoeconomics; 2008; 26(4):341-58. PubMed ID: 18370568
[TBL] [Abstract][Full Text] [Related]
17. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
18. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
19. Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia.
Achtyes E; Simmons A; Skabeev A; Levy N; Jiang Y; Marcy P; Weiden PJ
BMC Psychiatry; 2018 Sep; 18(1):292. PubMed ID: 30223804
[TBL] [Abstract][Full Text] [Related]
20. Method for Calculating the Simultaneous Maximum Acceptable Risk Threshold (SMART) from Discrete-Choice Experiment Benefit-Risk Studies.
Fairchild AO; Reed SD; Gonzalez JM
Med Decis Making; 2023 Feb; 43(2):227-238. PubMed ID: 36326189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
